Overview

DBPC Trial to Evaluate the Safety, Tolerability and Efficacy of Oral Litoxetine in Subjects With Urinary Incontinence

Status:
Completed

Trial end date:
2019-05-30

Target enrollment:

Participant gender:

Summary

This study will explore the safety, tolerability and efficacy of litoxetine in men and women who suffer from urinary incontinence

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Ixaltis SA